Shilpa Medicare Limited
 
 
LIST OF CERTIFICATE OF SUITABILITY (COS) GRANTED FROM EDQM
LIST OF KDMF SUBMISSION & APPROVAL DETAILS
LIST OF DMF SUBMIITED TO TPD, HEALTH CANADA
LIST OF ASMF SUBMISSION DETAILS FOR IRINOTECAN HCl TRIHYDRATE
LIST OF ASMF SUBMISSION DETAILS FOR OXALIPLATIN
LIST OF ASMF SUBMISSION DETAILS FOR GEMCITABINE HCl EP
LIST OF ASMF SUBMISSION DETAILS FOR TEMOZOLOMIDE
 
LIST OF CERTIFICATE OF SUITABILITY (COS) GRANTED FROM EDQM
Sr.No. Name of Active Ingredient
Date of COS Granted
CEP No.
01. Ambroxol HCl EP February 28 2008 R0-CEP 2004-201-Rev 01
04. Buflomedil HCl EP February 1, 2008 R0-CEP 2006-080-Rev 00
03. Carboplatin EP April 1 2009 R0-CEP 2006-212-Rev 01
06. Gemcitabine HCl EP March 24 2009 R0-CEP 2006-222-Rev 01
05. Oxaliplatin EP February 29, 2008 R0-CEP 2006-201-Rev 01
02. Ticlopidine HCl EP March 24 2009 R0-CEP 2005-004-Rev 02
 
LIST OF KDMF SUBMISSION & APPROVAL DETAILS
Sr.No. Name of Active Ingredient
Name of the Regulatory Authority
Date of Submission
01. Ambroxol HCl Korean FDA February 22, 2006
02. Gemcitabine Korean FDA January 4, 2007
 
LIST OF DMF SUBMIITED TO TPD, HEALTH CANADA
Sr.No. Name of Active Ingredient
Name of the Regulatory Authority
Date of Submission
04. Bicalutamide TPD, Health Canada March 28, 2005
02. Gemcitabine HCl TPD, Health Canada December 30, 2006
03. Gemcitabine HCl TPD, Health Canada June 8, 2007
01. Irinotecan HCl Trihydrate TPD, Health Canada December 28, 2006
05. Oxaliplatin TPD, Health Canada December 24, 2005
top
LIST OF ASMF SUBMISSION DETAILS FOR IRINOTECAN HCl TRIHYDRATE
Sr.No. Name of Active Ingredient Name of Regulatory Authority Country Dt. of Submission
01. Irinotecan HCl Trihydrate Medical Products Agency Sweden April 26, 2007
02. Irinotecan HCl Trihydrate AEMPS Spain April 26, 2007
03. Irinotecan HCl Trihydrate Medicines Evaluation Board The Netherlands April 26, 2007
04. Irinotecan HCl Trihydrate BASG Austria April 26, 2007
05. Irinotecan HCl Trihydrate Afdeling Registratie Belgium April 26, 2007
06. Irinotecan HCl Trihydrate State Institute for Drug Control Czech Republic April 26, 2007
07. Irinotecan HCl Trihydrate Laegemiddelstyrelsen Denmark April 26, 2007
08. Irinotecan HCl Trihydrate National Agency for Medicines Finland April 26, 2007
09. Irinotecan HCl Trihydrate Orszagos Hungary April 26, 2007
10. Irinotecan HCl Trihydrate Bfarm Germany April 26, 2007
11. Irinotecan HCl Trihydrate Irish Medicines Board Ireland April 26, 2007
12. Irinotecan HCl Trihydrate AIFA Italy April 26, 2007
13. Irinotecan HCl Trihydrate INFARMED Portugal April 26, 2007
14. Irinotecan HCl Trihydrate Office of Medicinal Products Poland April 26, 2007
15. Irinotecan HCl Trihydrate Norvegian Medicines Agency Norway April 26, 2007
16. Irinotecan HCl Trihydrate State Agency of Medicines Estonia April 26, 2007
17. Irinotecan HCl Trihydrate Latvia State Agency of Med. Latvia April 26, 2007
18. Irinotecan HCl Trihydrate State Medicines Control  Lithuania April 26, 2007
19. Irinotecan HCl Trihydrate State Institute for Drug Control Slovak Republic April 26, 2007
20. Irinotecan HCl Trihydrate MHRA UK June 6, 2007
21. Irinotecan HCl Trihydrate Bulgarian Drug Agency Bulgaria December 11, 2007
22. Irinotecan HCl Trihydrate The Registrar Drugs Council Cyprus December 11, 2007
23. Irinotecan HCl Trihydrate Registration Division, EOF Greece December 11, 2007
24. Irinotecan HCl Trihydrate AFSSAPS France December 11, 2007
25. Irinotecan HCl Trihydrate Division de la Pharmacie et des  Luxemburg December 11, 2007
26. Irinotecan HCl Trihydrate National Medicines Agency Romania December 11, 2007
27. Irinotecan HCl Trihydrate Agency for Medicinal Products Slovenia December 11, 2007
28. Irinotecan HCl Trihydrate Swissmedic Switzerland November 21 2008
top
LIST OF ASMF SUBMISSION DETAILS FOR OXALIPLATIN
Sr.No. Name of Active Ingredient Name of Regulatory Authority Country Dt. of Submission
01. Oxaliplatin EP MHRA  UK October 12, 2007
02. Oxaliplatin EP AEMPS Spain October 12, 2007
03. Oxaliplatin EP Medicines Evaluation Board The Netherlands October 12, 2007
04. Oxaliplatin EP National Medicines Agency Romania October 12, 2007
05. Oxaliplatin EP AIFA Italy October 12, 2007
06. Oxaliplatin EP INFARMED Portugal October 12, 2007
07. Oxaliplatin EP Medical Products Agency Sweden October 12, 2007
08. Oxaliplatin EP Lægemiddelstyrelsen Denmark October 12, 2007
09. Oxaliplatin EP BfArM Germany October 12, 2007
10. Oxaliplatin EP Office for Registration Poland October 12, 2007
11. Oxaliplatin EP AFSSAPS France December 17, 2007
top
LIST OF ASMF SUBMISSION DETAILS FOR GEMCITABINE HCl EP
Sr.No. Name of Active Ingredient Name of Regulatory Authority Country Dt. of Submission
01. Gemcitabine HCl EP TGA Australia April 25, 2008
02. Gemcitabine HCl EP Medsafe New Zealand April 25, 2008
03. Gemcitabine HCl EP BFSG Austria December 26, 2007
04. Gemcitabine HCl EP Federal Agency for Medicines Belgium December 26, 2007
05. Gemcitabine HCl EP Bulgarian Drug Agency Bulgaria December 26, 2007
06. Gemcitabine HCl EP State Institute for Drug Control Czech Rep. December 26, 2007
07. Gemcitabine HCl EP Lægemiddelstyrelsen Denmark December 26, 2007
08. Gemcitabine HCl EP State Agency of Medicines Estonia December 26, 2007
09. Gemcitabine HCl EP National Agency for Medicines Finland December 26, 2007
10. Gemcitabine HCl EP AFSSAPS France December 26, 2007
11. Gemcitabine HCl EP BFARM Germany December 26, 2007
12. Gemcitabine HCl EP Registration Division, EOF Greece December 26, 2007
13. Gemcitabine HCl EP Országos Gyógyszerészeti Intézet Hungary December 26, 2007
14. Gemcitabine HCl EP Icelandic Medicines Control Agency Iceland September 29 2008
15. Gemcitabine HCl EP Irish Medicines Board Ireland December 26, 2007
16. Gemcitabine HCl EP AIFA Italy April 17, 2008
17. Gemcitabine HCl EP State Agency of Medicines Latvia December 26, 2007
18. Gemcitabine HCl EP State Medicines Control Agency Lithuania December 26, 2007
19. Gemcitabine HCl EP Division de la Pharmacie et des  Luxembourg April 17, 2008
20. Gemcitabine HCl EP Medicines Authority Malta September 29 2008
21. Gemcitabine HCl EP Medicines Evaluation Board Netherlands December 26, 2007
22. Gemcitabine HCl EP Statens legemiddelverk Norway December 26, 2007
23. Gemcitabine HCl EP The Office for Registration  Poland December 26, 2007
24. Gemcitabine HCl EP INFARMED Portugal December 26, 2007
25. Gemcitabine HCl EP National Medicines Agency Romania December 26, 2007
26. Gemcitabine HCl EP State Institute for Drug Control Slovak Rep. December 26, 2007
27. Gemcitabine HCl EP Agency for Medicinal Products Slovenia December 26, 2007
28. Gemcitabine HCl EP AEMPS Spain December 26, 2007
29. Gemcitabine HCl EP Drug Agency of Republic of Srpska Srpska November 3 2008
30. Gemcitabine HCl EP Medical Products Agency Sweden December 26, 2007
31. Gemcitabine HCl EP MHRA UK December 26, 2007
32 Gemcitabine HCl EP The State Administration on Medicinal  Ukraine November 3 2008
top
LIST OF ASMF SUBMISSION DETAILS FOR TEMOZOLOMIDE
Sr.No. Name of Active Ingredient Name of Regulatory Authority Country Dt. of Submission
01. Temozolomide  EMEA London 29.01.2009
02. Temozolomide  INFARMED  Portugal 29.01.2009
03. Temozolomide Medical Products Agency Sweden 29.01.2009
04. Temozolomide CBG-MEB The Netherlands 13.02.2009
05. Temozolomide BfARM Germany 26.03.2009
 
top
 
Copyrights Reserved 2007. Shilpa Medicare Ltd. Disclaimer
Maintained by : vdesign2shine
 
Shilpa Medicare Limited